{
  "data": {
    "broad_sector": "PHARMA",
    "niche_industry": "Domestic Formulations (Acute Therapies) & US Generics",
    "sector_kpis": {
      "kpi_1": "India Sales Growth: 12.4% (Q2 FY26)",
      "kpi_2": "US Revenue Growth: 28.0% (Q2 FY26)",
      "kpi_3": "EBITDA Margin: 23.0% (Q2 FY26)"
    },
    "moat_rating": "Narrow",
    "competitive_position": "CHALLENGER"
  },
  "_cached_at": "2025-12-31T12:33:11.830915",
  "_symbol": "ALKEM"
}